Earnings call transcript: Intrum Justitia Q1 2026 shows mixed results

Intrum Justitia’s Q1 2026 revenue fell 12% year over year to SEK 4.12 billion, with negative net income driven by FX headwinds and non-cash accounting items, though servicing margins improved to 21% from 20%. The stock fell 24.72% pre-market after the report, despite management highlighting a SEK 254 million capital gain from Savoy consolidation and progress on AI/operational efficiency initiatives. The company also announced a fully guaranteed SEK 7.5 billion rights issue, with about SEK 5 billion earmarked for debt reduction and leverage now targeted to fall to around 3x by 2028, two years earlier than previously planned.

Analysis

The market is reacting to a bad headline, but the more important signal is that management is effectively using the raise to refinance the equity story as much as the balance sheet. For creditors and holders of the capital structure, the near-term winner is the shortest-duration paper: forced de-risking should tighten refinancing spreads first at the front end, while longer-dated notes still need execution proof. The equity, however, is still trading like a levered runoff asset; that disconnect leaves room for a relief rally if the raise clears and ratings agencies signal even a modest upgrade trajectory.

The second-order effect is that the company is trying to turn AI into an operating margin bridge rather than a future growth call option. If automation actually lowers cost-to-collect and accelerates onboarding, the upside does not show up evenly across the P&L: it should first support servicing margins and only later convert into top-line retention. That means competitors with weaker automation and higher manual operating intensity are more exposed to share loss in the same geographies, especially where economics are already deteriorating and pricing discipline matters.

The bigger contrarian point is that the market may be over-discounting the structural decline narrative before seeing the full capital allocation impact. If management really can reduce funding cost quickly and redeploy even a portion of capital into higher-IRR portfolio purchases, earnings power can inflect faster than the current consensus expects over the next 2-4 quarters. The risk, though, is that FX stays adverse and the raise is read as patching over a slower underlying servicing franchise; in that case, the equity rerates lower again once the one-time financing excitement fades.

Key Decisions for Investors

• Long the common on weakness only after the rights issue is formally approved and priced; target a 1-3 month mean reversion trade if execution de-risks, but cut if FX remains a persistent headwind into the next quarter.
• Buy the shortest-dated senior unsecured or buy protection on the nearest refinancing tranche only if it widens on the news; the front end should benefit first from immediate deleveraging and lower revolver usage.
• Pair trade: long shorter-duration debt / short equity for 1-2 quarters to express the view that balance-sheet repair is more certain than earnings recovery.
• If listed options are available, consider a call spread on the equity into the capital raise close, financed against downside risk from a failure-to-execute or weak market appetite for the offering.
• Avoid chasing any rally in the equity until management proves that AI savings are real cash savings; the cleanest catalyst is not the narrative, but a second-quarter confirmation of margin expansion without additional FX slippage.